🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users administering substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The company said it was committed to keeping the service secure and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at residence.

Within moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Item Information and Pricing

Within these groups, posts show black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.